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It has been demonstrated that the subcellular location of Tobamovirus movement protein (MP) which was fused with green fluorescent protein
(MP:GFP) changed during the infection process. However, the intracellular route through which MP is transported and its biological meaning are
still obscure. Treatment with brefeldin A (BFA), which disrupts ER-to-Golgi transport, inhibited the formation of irregularly shaped and
filamentous structures of MP. In this condition, MP was still targeted to plasmodesmata in leaf cells. Furthermore, the viral cell-to-cell movement
was not inhibited by BFA treatment. These data indicated that the targeting of viral replication complexes (VRCs) to plasmodesmata is mediated
by a BFA-insensitive pathway and that the ER-to-Golgi transport pathway is not involved in viral intercellular movement.
© 2006 Elsevier Inc. All rights reserved.Keywords: Tobamovirus; Movement protein; Cell-to-cell movement; Brefeldin A; ER-to-Golgi pathway; PlasmodesmataIntroduction
Most plant viruses encode one or more proteins to facilitate
spreading from the initially infected cells to adjacent cells, to
achieve local and systemic infection in the host. These so-called
movement proteins (MPs) enable viruses to exploit plasmo-
desmata, which provide symplastic continuity and intercellular
communication between adjacent cells (Epel, 1994; Heinlein
and Epel, 2004). The functions of MP have been well-studied in
Tobacco mosaic virus (TMV), the type member of the genus,
Tobamovirus (reviewed in Boevink and Oparka, 2005; Lucas,
2006; Scholthof, 2005; Waigmann et al., 2004). In TMV-
infected tobacco plants, as well as in plants transgenically
expressing MP, MP accumulates in plasmodesmata and
increases their size exclusion limit (SEL) (Waigmann et al.,
1994; Wolf et al., 1989). MP also binds single-stranded nucleic
acids in vitro, forming unfolded and elongated protein-nucleic
acid complexes (Citovsky et al., 1990). It is generally accepted
that the virus moves from cell to cell in the form of a viral
ribonucleoprotein complex (vRNP) (Citovsky et al., 1992;⁎ Corresponding author. Fax: +81 3 5454 6776.
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doi:10.1016/j.virol.2006.11.008Dorokhov et al., 1984). It is quite possible that MP and vRNP
recruit some host components to assist their own translocation
through the plasmodesmata.
TMV derivatives that encode MP fused with green
fluorescent protein (MP:GFP) have been used to determine
in which subcellular compartments MP accumulates. Pre-
vious studies demonstrated that MP:GFP fluorescence was
localized not only to the plasmodesmata but also to other
structures, such as the endoplasmic reticulum (ER) or
cytoskeleton, both in protoplasts and leaf cells (Heinlein et
al., 1995, 1998; Mas and Beachy, 1999; McLean et al.,
1995; Reichel and Beachy, 1998).
Membrane-associated complexes that contain MP, replicase
and genomic RNAs are formed, originating from the ER, and
have been designated as viral replication complexes (VRCs)
(Asurmendi et al., 2004; Mas and Beachy, 1999). Kawakami et
al. (2004) demonstrated that the VRC spreads from primary
infected cells to secondary infected cells by 20 h post-infection
(hpi). But the nature of the motile VRC entity is still obscure.
The ER of plants is a dynamic organelle of discrete functional
domains (Staehelin, 1997), and the formation of the VRC
should be of general interest towards understanding of the plant
ER as well as virus movement.
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the ER-to-Golgi secretory pathway (Nebenfuhr et al., 2002). To
investigate the relation between ER-to-Golgi secretory pathway
and MP localizations, intracellular locations of MPs of Grape-
vine fanleaf virus (Laporte et al., 2003) and Cowpea mosaic
virus (Pouwels et al., 2002) were investigated in detail in the
presence of BFA. However, these studies were restricted to
cultured cells, in which virus cell-to-cell movement ability
could not be discussed.
In this study, we used BFA to test whether the ER-related
secretory pathway is involved in MP localization and realization
of viral cell-to-cell movement in leaves using Tomato mosaic
virus (ToMV), a member of the Tobamovirus family. Our
results showed that BFA did not inhibit, at least, the primary
establishment of viral trafficking to the adjacent cells, and that
MP moves to plasmodesmata via a BFA-insensitive route in
infected cells. Using cell fractionation procedures we investi-
gated the intracellular localization of ToMV MP, and tested its
association with Golgi bodies and plasma membrane along with
the ER, and confirmed that MP is not associated with Golgi
bodies. Taking these results together, we could infer that the
conventional ER-to-Golgi pathway is not involved in Toba-
movirus intercellular movement.
Results
The subcellular localization of ToMV MP:GFP
To begin this study of the involvement of the ER-to-Golgi
pathway, we first checked the subcellular localization of MP of
ToMV in the BY-2 protoplast system, to compare the
intracellular localization in detail with previous data from
TMV, a virus closely related to ToMV. BY-2 protoplasts were
infected with ToMV-MP:GFP, a ToMV expressing MP fused
with GFP (Fig. 1) (Kawakami et al., 1999; Kawakami and
Watanabe, 1997). MP:GFP fluorescence was examined under a
fluorescence microscope until 24 hpi.
We could categorize the fluorescence patterns produced by
MP:GFP into five groups (Fig. 2A), based on the fluores-
cence localization pattern inside the cells. The frequency of
protoplasts exhibiting each fluorescence pattern is dia-
grammed in Fig. 2B. MP:GFP fluorescence was faintly
visible at 6 hpi in the ER network (Fig. 2A, ER). At 8 hpi
MP:GFP was seen also in peripheral punctate structuresFig. 1. Schematic drawings of viruses. Wild-type ToMV encodes four genes,
126 K and 183 K replication proteins (RdRp), movement protein (MP) and coat
protein (CP). ToMV-MP:GFP expresses MP:GFP fusion protein. ToMV-ΔC-
GFP expresses GFP under the control of the CP promoter.(indicated with arrowheads, Fig. 2A) together with scattered
ER localization (Fig. 2A, ER+punctate spots). After 8 hpi
these punctate spots were visible in most protoplasts with a
variety of intracellular complex fluorescence patterns. At 8–
14 hpi many irregularly shaped structures were formed inside
the cells (Fig. 2A, irregular structures+punctate spots). The
structures grew and coalesced to form larger structures,
gathering around nuclei and just beneath cell surfaces. At 14–
18 hpi MP:GFP seemed to form cytoplasmic bridges between
aggregations around the nuclei and below the cell periphery
(Fig. 2A, radial filaments+punctate spots). After 20 hpi, MP:
GFP was observed in the form of filaments at the cortical
region of the cells, in close proximity to the plasma
membrane (Fig. 2A, cortical filaments+punctate spots).
From these observations over time, we assumed that two
routes of MP intercellular movement were observed together in
infected cells. In one route, MP:GFP accumulates at the
peripheral punctate spots from early through late stages of
infection. In the other route, MP:GFP at first accumulates in the
form of irregularly shaped structures around the nuclei, then is
transported to the cell periphery via the cytoplasm, and finally
forms filamentous structures at the cell cortex during the middle
to late stages of infection.
Next we investigated the MP:GFP accumulation patterns in
tobacco leaf cells inoculated with ToMV-MP:GFP. Inoculation
of leaves with virus expressing the MP:GFP produces
fluorescent rings which have newly infected cells at the edges
of the rings and cells at the later stages of the infection in the
center of the rings (Szecsi et al., 1999). MP:GFP mainly
accumulated at the punctate spots (indicated by arrowheads,
Fig. 2C) which seemed to be the plasmodesmata at the leading
edge of the infection (Fig. 2C, leading edge). In the middle of
the fluorescent ring, large irregularly shaped structures were
formed (indicated with arrows, Fig. 2C, middle). Filamentous
structures were barely visible at the center of the fluorescent
rings, which were clearly observed in protoplasts (see above).
However, the punctate spots between cells were observed in
leaves (Fig. 2C, center). It was previously described that
filamentous fluorescence was observed with TMV-MP:GFP in
leaf cells (Heinlein et al., 1998). In ToMV, the filamentous
fluorescence of MP:GFP in leaves, if any, was much less visible
than that in protoplasts. From these observations we consider
that the filamentous structures of MP may be unrelated to MP
function, i.e., facilitating cell-to-cell movement, as has been
previously suggested (Gillespie et al., 2002).
Effect of BFA treatment on ToMV MP:GFP localization in
protoplast
Considering the association of MP with the ER, it is possible
that ER-to-Golgi membrane trafficking could play a role in MP
dynamics and/or functions. To investigate this possibility, we
applied BFA and evaluated its effect on subcellular localization
and function of MP. BFA is a fungal metabolite known to
prevent normal functioning of the ADP-ribosylation factor
(ARF) family of small GTPases, followed by Golgi tubulation
and fusion with the ER (Nebenfuhr et al., 2002).
Fig. 2. Changing patterns of MP:GFP fluorescence. (A) Representative images of MP:GFP fluorescent patterns in protoplasts infected with ToMV-MP:GFP. Peripheral
punctate spots indicated with arrowheads were observed irrespective of the MP:GFP fluorescence pattern inside the cells. Bars=10 μm. (ER) MP:GFP fluorescence is
observed only at the ER network. (ER+punctate spots) MP:GFP accumulated at the ER and punctate spots at the cell periphery. (Irregular structures+punctate spots)
MP:GFP mainly accumulated at irregularly shaped structures together with peripheral punctate spots. (Radial filaments+punctate spots) MP:GFP is observed
interlinking the aggregates between the nucleus and cell periphery and at the punctate spots. (Cortical filaments+punctate spots) MP:GFP is accumulated at cortical
filamentous structures and punctate spots. (B) Frequency of protoplasts with each MP:GFP fluorescent pattern at indicated time after infection. About 200 cells were
counted at each time. (C) MP:GFP fluorescence patterns in leaf cells inoculated with ToMV-MP:GFP at the leading edge, middle, and center of the fluorescent ring.
Arrowheads indicate the punctate spots and arrows indicate the irregularly shaped structures. Bars=100 μm.
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plasmid directing the expression of the Erd2 protein fused to
GFP (Erd2:GFP), under control of the cauliflower mosaic virus
35S promoter, was electroporated into protoplasts (Takeuchi et
al., 2000). Erd2 is an integral membrane protein localized in the
cis region of the Golgi apparatus (Lee et al., 1993; Semenza etal., 1990). Therefore, Erd2:GFP fluorescence was used as a
marker to observe ER-to-Golgi transport and its inhibition by
BFA. In protoplasts expressing Erd2:GFP, fluorescence was
observed in many small dots representing Golgi bodies (Fig.
3A, +DMSO). Within 1 h after 10 μg/ml BFA treatment, the
“dotty” Golgi pattern changed to an ER network pattern that
Fig. 3. Effect of brefeldin A on MP:GFP localization in protoplasts. (A) Erd2:
GFP (Golgi resident protein) images in protoplasts with or without BFA at 15 h
after treatment. Bars=10 μm. (B) MP:GFP fluorescence in the presence of BFA
in protoplasts infected with ToMV-MP:GFP at 12 hpi. Arrowheads indicate the
punctate spots at the cell periphery. Bar=10 μm. (C) Frequency of each MP:
GFP fluorescent pattern in protoplasts at indicated time after infection with or
without BFA. About 200 cells were counted in each condition.
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as has previously been shown (Takeuchi et al., 2000). These
data confirmed that our BFA treatment prevented the transport
to Golgi bodies from the ER in protoplast system.
To investigate the effect of BFA on MP localization,
protoplasts infected with ToMV-MP:GFP were incubated with
10 μg/ml BFA at 1 h after infection. Throughout the infection
process, about 60–70% of the cells showed the MP:GFP
fluorescence in the ER network and, in addition, clearly at the
peripheral punctate spots (Fig. 3B, C). The number of cells
showing irregularly shaped structures and filamentous struc-
tures was much reduced in the presence of BFA. This
observation is not consistent with those observed for TMV-
MP:GFP-infected cells treated with BFA (Heinlein et al., 1998).
In the protoplasts infected with TMV-MP:GFP, BFA treatmentinhibited GFP localization not only in the irregularly shaped
structures and filamentous structures but also at the punctate
spots (Heinlein et al., 1998). We consider that this may be due
to the weak fluorescence of TMV-MP:GFP. When BFA was
added to the infected protoplasts at 12 hpi, there was no
difference observed in MP:GFP localization relative to the
control (data not shown), as has been described previously
(Heinlein et al., 1998). Here we reasoned that the MP traf-
ficking to the punctate sites at the cell periphery is not mediated
by the ER-to-Golgi secretory pathway, while the formations of
irregularly shaped structures and filamentous structures are
BFA-sensitive and the Golgi-related secretory pathway may be
involved.
Effect of BFA treatment on ToMV MP:GFP localization in
leaves
To investigate the effect of BFA on MP:GFP subcellular
localization in tobacco leaves, we confirmed that BFA inhibited
the ER-to-Golgi pathway in leaves as well as in protoplasts.
Tobacco leaves were infiltrated with Agrobacterium carrying
Erd2:GFP expressing plasmid and, after 2 days, infiltrated with
10 μg/ml BFA solution. In control leaf cells, Erd2:GFP showed
the dotty Golgi pattern as well as in protoplasts (Fig. 4A,
+DMSO, 30 min). However, dotty Golgi patterns were
disrupted in the presence of BFA in 30 min (Fig. 4A, +BFA,
30 min). This effect persisted until 24 h after BFA treatment
(Fig. 4A, +BFA, 24 h). Therefore, we could confirm that BFA
prevented ER-to-Golgi secretory pathway in leaf cells until at
least 1 day after treatment.
Next we investigated the effect of BFA on MP:GFP
subcellular localization in tobacco leaves (Fig. 4B). Leaves
inoculated with ToMV-MP:GFP were infiltrated with BFA
solution at 2 days post-inoculation (dpi) and MP:GFP was
observed 1 day after the BFA treatment. The fluorescence was
seen at the spots between cells at the leading edge of the
fluorescent ring (Fig. 4B, leading edge) and at the irregularly
shaped structures (Fig. 4B, middle) in the middle of the
fluorescent ring. These data confirmed that the BFA treatment
does not inhibit the MP targeting to punctate spots in leaves as
well as in protoplasts. Furthermore, BFA did not have any effect
on the irregularly shaped structures once they were established,
in the leaves as well as in protoplasts.
Effect of BFA on ToMV cell-to-cell movement
To address the relation between MP localization and viral
cell-to-cell transport, we next investigated the ability for cell-to-
cell movement of the virus in the presence of BFA. In the leaves
inoculated with ToMV-ΔC-GFP (Fig. 1), the sizes of GFP-
fluorescence disks reflect the ability of viral cell-to-cell
movement (Szecsi et al., 1999). At 2 dpi, tobacco leaves
inoculated with ToMV-ΔC-GFP were infiltrated with 10 μg/ml
BFA solution or 0.1% DMSO as a control. After 1 day (i.e.,
3 dpi) the diameter of GFP fluorescence was measured (Fig.
4C). There was no significant difference in the diameters of the
GFP-fluorescence disks between control and BFA-treated
Fig. 4. Effect of brefeldin A on MP:GFP localization in leaves and ToMV cell-
to-cell movement. (A) Erd2:GFP images in leaf cells with or without BFA at
30 min and 24 h after treatment. Bar=50 μm. (B) MP:GFP fluorescence
patterns in leaf cells infected with ToMV-MP:GFP 3 days post inoculation and
1 day after BFA treatment. Arrowheads indicate the punctate spots and arrows
indicate the irregularly shaped structures. Bars=50 μm. (C) The average
diameters of GFP-disks observed on tobacco leaf inoculated with ToMV-ΔC-
GFP before BFA treatment (2 dpi) and 1 day after BFA treatment (3 dpi)
(n=10). DMSO treatment was performed as a control. Bars indicate standard
deviations.
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movement of virus. Taken together, these results suggest that
the ER-to-Golgi secretory pathway is not involved in MP
targeting to plasmodesmata and MP function (viral cell-to-cell
transport).MP is primarily localized to the ER and not trafficked to Golgi
bodies
Previous studies using cell fractionation and immunostaining
techniques demonstrated that TMV MP was associated with the
ER (Heinlein et al., 1998; Mas and Beachy, 1999; Reichel and
Beachy, 1998). To investigate the association of ToMVMPwith
the ER or other organelles, we performed cell fractionation
using BY-2 protoplasts infected with ToMV (Fig. 5). Fig. 5A
shows theWestern blot analysis of MP and marker proteins. Fig.
5B shows the quantification of their distribution patterns shown
in Fig. 5A. We used anti-BiP antibody as an ER marker (Hatano
et al., 1997), anti-RGP1 antibody as a Golgi complex marker
(Dhugga et al., 1997) and anti-PMA2 antibody as a plasma
membrane marker (Morsomme et al., 1998).
The main fractions containing MP showed a shift between
the absence and presence of Mg2+, MP was alternatively found
in fractions 13–15 (−Mg2+) and 4–10 (+Mg2+). A similar shift
appeared in the anti-BiP distributions. While BiP showed very
broad distribution patterns, it was mainly detected in fractions
14–17 (−Mg2+) and 6–11 (+Mg2+). This phenomenon is
generally called magnesium-shift and is explained by the fact
that ribosomes are bound to the ER in the presence of Mg2+ but
are released in the absence of Mg2+. Peak fractions of MP also
showed the magnesium-shift, while RGP1 and PMA2 did not
display this magnesium-shift. Therefore, these data strongly
supported the notion that ToMV MP is mainly associated with
the ER and not with Golgi bodies. Still, the possibility that MP
associated with the plasma membrane could not be eliminated
completely because both the minor peak of MP in the absence of
Mg2+ (fractions 6–10) and the major peak of MP in the presence
of Mg2+ (fractions 4–10) were overlapped with the peaks of
anti-PMA2 (fractions 4–11).
Discussion
In this study we re-examined the time-dependent shift of
intracellular localization of MP:GFP fusion protein using
ToMV, a different Tobamovirus from the well-studied TMV,
and its relation to MP function in viral cell-to-cell movement, by
focusing on the ER-to-Golgi vesicle transport pathway.
In protoplasts infected with ToMV-MP:GFP, MP:GFP first
appeared (at 6–8 hpi) in peripheral punctate structures and
persisted in this location throughout infection. At ∼14 hpi, MP:
GFP also began to accumulate in irregularly shaped structures
possibly derived from the ER, as suggested by previous studies
with TMV (Heinlein et al., 1998; Mas and Beachy, 1999;
Reichel and Beachy, 1998). These irregularly shaped structures
were designated as VRCs (viral relplication complexes) which
contain MPs, viral replicases and genomic RNAs, and move in
the infected cell of an intact plant (Kawakami et al., 2004; Liu et
al., 2005). These VRCs grew in size and then disappeared. MP:
GFP was redistributed to cortical filamentous structures as well
as the peripheral punctate sites that could be seen from the early
stages.
BFA, a well-established drug causing inhibition of ER-to-
Golgi vesicle transport, altered the MP:GFP temporal shift
Fig. 5. MP association with ER. (A) Immunoblot analyses of sucrose density gradient fractionation using protoplasts infected with ToMVat 12 hpi. Anti-BiP, RGP1
and PMA2 antibodies are used as ER, Golgi and plasma membrane markers, respectively. The shift in MP location with magnesium treatment is most like the shift
observed for anti-BiP fractions, indicating ER association for the MP. (B) Quantified distribution curves of Western blot analyses of (A).
Fig. 6. A model for intracellular dynamics of the ToMV MP and its relationship
with virus cell-to-cell movement. In the initially infected cell, viral RdRp is
translated and it produces the viral genomic RNA (vgRNA). RdRp, MP and
vgRNA accumulate at the ER and form viral replication complexes (VRCs)
(Kawakami et al., 2004). VRCs move to plasmodesmata along with actin
filaments (Kawakami et al., 2004; Liu et al., 2005) and move to the adjacent cell
as a form of virus movement complex (VMC), which is a BFA-insensitive
pathway. MPs modify plasmodesmata and facilitate vgRNA transport to
adjacent cells. At the same time, VRCs accumulate around the nucleus, move to
the cell cortex and form filamentous structures. This is a BFA-sensitive pathway
and is not involved in viral cell-to-cell movement. The source of the large VRCs
is not clear (indicated with dotted line).
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localized only in the ER network and punctate structures at the
cell periphery throughout the infection process, but not in the
irregularly shaped structures or filamentous structures as was
seen in the absence of BFA. These results led us to speculate
that two pathways exist for MP subcellular localization, as
shown in Fig. 6; (1) MP is transported to plasmodesmata via a
BFA-insensitive (Golgi-independent) pathway from the early to
late stages of infection. (2) MP forms larger VRCs derived from
the ER and is then redistributed to cortical filamentous
structures from the middle to the late stages of infection.
Because this shift was not observed in the presence of BFA, the
modification of Golgi production may affect this process.
The effect of inhibition of ER-to-Golgi transport on ToMV
cell-to-cell movement was investigated by using BFA (Fig. 4C).
Inhibition of the ER-to-Golgi secretory pathway did not have an
effect on cell-to-cell movement of the virus. Considering the
effect of BFA on MP localization and the absence of
filamentous fluorescence in leaf cells infected with ToMV-
MP:GFP (Fig. 2C, center), we reasoned that the formation of
large VRCs and targeting of MP to filamentous structures are
not required for cell-to-cell movement of virus.
Taking these results together, the mechanism of viral
intercellular transport is summarized in Fig. 6. VRCs, derived
from the ER membrane, move to plasmodesmata from early to
late stages of infection by trafficking possibly along actin
filaments (Kawakami et al., 2004; Liu et al., 2005; Szecsi et al.,1999). Plasmodesmata are modified by MP and VMCs (virus
movement complexes) to establish propagation to the adjacent
cell (Kawakami et al., 2004). This pathway is probably
mediated only by the ER membrane because it was not affected
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stage of infection and move to the cell periphery where they
form filamentous structures at the later stages of infection. This
activity is possibly mediated by the ER-Golgi pathway because
it is inhibited by BFA. It was reported in a study using mutated
TMV that large VRCs were not necessary for virus movement
(Liu et al., 2005). It was also reported that treatment with
proteasome inhibitors prevented the targeting of MP to
filamentous structures, indicating that the filamentous arrange-
ment of MP might be involved in viral protein degradation in
host cells (Gillespie et al., 2002). Our findings firmly support
these previous suggestions.
There are several cases where the endomembrane traffic
system of the host is utilized in dissemination of viruses. Tomato
bushy stunt virus replication protein p33 is localized in novel
cytosolic vesicles originating from peroxisomes. Later in infec-
tion, it is relocalized to the peroxisomal endoplasmic reticulum
(McCartney et al., 2005). It was also reported that the endocytic
recycling pathway is involved in the intracellular movement of
Potato mop-top virus TGB2 and TGB3 (Haupt et al., 2005).
Each virus may induce unique intracellular rearrangement
strategies for their multiplication and cell-to-cell transport.
Materials and methods
Plant materials
Nicotiana benthamiana plants were grown from seeds and
maintained at 22 °C in a growth chamber with a photoperiod of
17 h and a mean photon flux density of 80 μmol m−2 s−1. Six-
to eight-week-old plants were used for virus inoculation and
transient expression.
Viruses
The plasmids pTLQG3 and pTLΔCG3 were used as
templates for production of ToMV-MP:GFP and ToMV-ΔC-
GFP infectious RNA, respectively (Kawakami and Watanabe,
1997). Schematic representations of viruses are shown in
Fig. 1.
Inoculation of virus
Protoplasts were prepared from tobacco BY-2 suspension
culture cells and inoculated with infectious transcripts derived
from in vitro reactions by electroporation, essentially as
previously described (Watanabe et al., 1987). Cells (5×105)
were electroporated with infectious transcripts. After inocula-
tion, 1×105 cells were cultured in each 35-mm Petri dish, in the
dark at 28 °C. For the inoculation of plants, leaves were dusted
with carborundum and gently rubbed with infectious transcripts
using brushes.
Transient expression of Erd2:GFP
To confirm the effect of BFA, we used locations of GFP
fused with Erd2 (Golgi resident protein) as a marker. Forprotoplasts, 10 μg of pMT121-AtERD2-GFP (Takeuchi et al.,
2000) was used for electroporation as described in “Inoculation
of virus”. For leaves, leaves of N. benthamiana were infiltrated
with Agrobacterium carrying pBI121-AtERD2-GFP. Both
plasmids were kindly gifted from Dr. Akihiko Nakano
(RIKEN).
Treatment with inhibitor
A stock of brefeldin A (BFA, Sigma) was made at 10 mg/ml
in DMSO and diluted to 10 μg/ml for use in experiments.
Protoplasts were treated with BFA by adding the stock solution
into the medium 1 h after infection. Plant leaves were infiltrated
into the abaxial side (underside) with BFA solution 2 days after
inoculation. In each experiment, treatment with 0.1% DMSO
was used as a control.
Microscopic analysis
GFP fluorescence images were observed by fluorescence
microscopy using an Olympus IX70-inverted system micro-
scope equipped with an IX-FLA inverted reflected light
fluorescence observation attachment and the U-MWIB/GFP
filter cube (BP 460–490, DM 505, BA 510IF, Olympus).
Images of protoplasts were acquired by using a confocal laser
scanning microscope system (LSM 510, Zeiss). Images of leaf
cells were acquired using the microscope system, IX-70 and IX-
FLA (Olympus) and the software SimplePCI (Compix Inc.). To
estimate the frequency of each MP:GFP distribution pattern,
about 200 infected protoplasts were counted for each condition.
For measuring the diameters of GFP disks, 10 disks were
imaged.
Cell fractionation and immunoblot analysis
Protoplasts (1×106) infected with ToMV were collected at
12 hpi. Lysis buffer (400 μl; 150 mM Tris–HCl pH 7.5,
10 mM KCl, 1 mM EDTA, 13.5% sucrose, 0.5 mM PMSF,
0.5 μg/ml leupeptin, 0.5 μg/ml pepstatin, with/without 3 mM
MgCl2) was added and cells were lysed using a syringe (27 G).
Cell lysate was centrifuged at 500×g for 5 min. The super-
natant was placed onto the sucrose density gradient (100 mM
Tris–HCl pH 7.5, 10 mM KCl, 1 mM EDTA, with/without
3 mM MgCl2, 21–55% sucrose) and centrifuged at 100,000×g
for 14 h (CP70MX, Hitachi). Samples were divided into 18
fractions according to the sucrose density and used for
immunoblot analysis.
For immunoblotting, proteins were separated by SDS-PAGE
and were blotted onto PVDF membranes (Millipore). As
primary antibodies, anti-MP antibody (1:1000; Meshi et al.,
1987), anti-BiP antibody (1:1000; Hatano et al., 1997), anti-
RGP1 antibody (1:10,000; Dhugga et al., 1997) and anti-PMA2
antibody (1:5000; Morsomme et al., 1998) were used. Anti-
rabbit IgG, horseradish peroxidase-linked whole antibody
(Amersham Biosciences) was used as the secondary antibody
and was detected with ECL plus Western blotting detection
reagents (Amersham Biosciences).
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